Vor Biopharma
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Vor Biopharma
RECRUITINGPhase 3NCT06456580
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
The purpose of this study is to evaluate the efficacy and safety of telitacicept in the treatment of generalized myasthenia gravis.
Sponsor: Vor BiopharmaEnrolling: 18020 locations
Generalized Myasthenia Gravis
RECRUITINGPhase 3NCT07404865
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease (UPSTREAM SjD)
Sponsor: Vor BiopharmaEnrolling: 2505 locations
Primary Sjogren's Disease